A detailed history of Occidental Asset Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Occidental Asset Management, LLC holds 11,623 shares of TGTX stock, worth $350,782. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,623
Previous 11,623 -0.0%
Holding current value
$350,782
Previous $271,000 28.78%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021

SELL
$32.5 - $48.96 $262,502 - $395,449
-8,077 Reduced 41.0%
11,623 $451,000
Q1 2021

May 06, 2021

BUY
$41.61 - $54.3 $819,717 - $1.07 Million
19,700 New
19,700 $950,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.38B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.